Sandbox:Roukoz: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | |E02| | | | | | | | E02=Gender specific tests}}
{{familytree | | | | | | | | | |E02| | | | | | | | E02=Gender specific tests}}
{{familytree | | | | |,|-|-|-|-|+|-|-|-|-|.| | | }}
{{familytree | | | | | |,|-|-|-|+|-|-|-|.| | | | }}
{{familytree | | | | |F01| | | | |F02| | | |F03| | | |}}
{{familytree | | | | | |''Male''<br> • PSA <br> •aFP <br> •BHCG | | | | | | | |''Female''<br> • Mammography<br> • Ultrasound or pelvic CT| | | | }}


{{familytree/end}}
{{familytree/end}}

Revision as of 18:13, 10 October 2018

 
 
 
 
 
 
 
 
Tumor of unknown primary origin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Full medical history and physical exam
• Basic blood and bichemical analysis
• CT scan of chest, abdomen, and pelvis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathologic examination
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Squamous cell carcinoma
 
 
 
 
Adenocarcinoma and poorly differntiated carcinoma
 
 
 
 
Neuroendocrine carcinoma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gender specific tests
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{Male
• PSA
•aFP
•BHCG }}}
 
 
 
 
 
 
 
{{{Female
• Mammography
• Ultrasound or pelvic CT}}}